Skip to content
Business Times – Lifestyle
Author:
Endo Tools Therapeutics S.A. / SPRIG Consulting
Endo Tools Therapeutics Appoints Devon Bream as Chief Executive Officer
July 22, 2026
Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System
July 16, 2026
Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation endomina® EZFuse system
March 17, 2026